Nunn Jason Raleigh insider trades
Nunn Jason Raleigh has filed 15 Form 4s with the SEC that we hold, for RGLS (Director), Zenas BioPharma, Inc. (ZBIO) (Director), TRVN (Director) and Addex Therapeutics Ltd. (ADXN) (Director). Across all of them we count 2 purchases worth $8.7M and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 441,176 shares of Zenas BioPharma, Inc. worth $7.5M, dated 2024-09-16. The first filing on our record is dated 2022-06-10 and the latest 2026-09-04.
RGLS
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Zenas BioPharma, Inc. (ZBIO)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-09-16 | P, purchase reported on Form 4 | 441,176 | $7.5M | 2024-09-16 |
| 2025-10-09 | P, purchase reported on Form 4 | 63,158 | $1.2M | 2025-10-14 |
TRVN
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Addex Therapeutics Ltd. (ADXN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1444319) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms